等待开盘 05-30 09:30:00 美东时间
-0.020
-0.42%
-SEC Filing
05-29 05:12
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
Needham analyst Matt Dezort reinstates Telos (NASDAQ:TLS) with a Buy and announces $6 price target.
05-26 18:22
Telos (NASDAQ:TLS) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.02 by 200 percent. This is a 300 percent increase over losses of $(0.03) per share from the same period
05-11 21:06
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
https://www.sec.gov/ix?doc=/Archives/edgar/data/320121/000032012126000012/tls-20260428.htm
04-30 04:45
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
Wedbush analyst Dan Ives maintains Telos (NASDAQ:TLS) with a Outperform and lowers the price target from $10 to $8.
03-17 20:38
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Telos业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第四季度2025年业绩:** - 营收:4,680万美元,同比增长77%,超出指导区间上限(4,400万-4,630万美元) - 毛利率(GAAP):35%;调整后毛利率:36%;现金毛利率:41.9% - 调整后EBITDA:730万美元,EBITDA利润率15.6%,超出指导区间(400万-570万美元) - 经营现金流:800万美元 - 自由现金流:630万美元,自由现金流利润率13.4% **2025年全年业绩:** - 营收:16,480万美元,同比增长52% -
03-17 12:24
Telos shares are trading higher after the company reported better-than-expected...
03-16 21:19